{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:36:45Z","timestamp":1794933405497,"version":"4.9.1"},"reference-count":49,"publisher":"Society for Neuroscience","issue":"19","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":227,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neurosci."],"accepted":{"date-parts":[[2023,3,15]]},"published-print":{"date-parts":[[2023,5,10]]},"abstract":"<jats:p>Metachromatic leukodystrophy (MLD) is a rare, inherited, demyelinating lysosomal storage disorder caused by mutations in the arylsulfatase-A gene (<jats:italic>ARSA<\/jats:italic>). In patients, levels of functional ARSA enzyme are diminished and lead to deleterious accumulation of sulfatides. Herein, we demonstrate that intravenous administration of HSC15\/<jats:italic>ARSA<\/jats:italic>restored the endogenous murine biodistribution of the corresponding enzyme, and overexpression of<jats:italic>ARSA<\/jats:italic>corrected disease biomarkers and ameliorated motor deficits in<jats:italic>Arsa<\/jats:italic>KO mice of either sex. In treated<jats:italic>Arsa<\/jats:italic>KO mice, when compared with intravenously administered AAV9\/<jats:italic>ARSA,<\/jats:italic>significant increases in brain ARSA activity, transcript levels, and vector genomes were observed with HSC15\/<jats:italic>ARSA<\/jats:italic>. Durability of transgene expression was established in neonate and adult mice out to 12 and 52 weeks, respectively. Levels and correlation between changes in biomarkers and ARSA activity required to achieve functional motor benefit was also defined. Finally, we demonstrated blood\u2013nerve, blood\u2013spinal and blood\u2013brain barrier crossing as well as the presence of circulating ARSA enzyme activity in the serum of healthy nonhuman primates of either sex. Together, these findings support the use of intravenous delivery of HSC15\/<jats:italic>ARSA<\/jats:italic>-mediated gene therapy for the treatment of MLD.<\/jats:p><jats:p><jats:bold>SIGNIFICANCE STATEMENT<\/jats:bold>Herein, we describe the method of gene therapy adeno-associated virus (AAV) capsid and route of administration selection leading to an efficacious gene therapy in a mouse model of metachromatic leukodystrophy. We demonstrate the therapeutic outcome of a new naturally derived clade F AAV capsid (AAVHSC15) in a disease model and the importance of triangulating multiple end points to increase the translation into higher species via ARSA enzyme activity and biodistribution profile (with a focus on the CNS) with that of a key clinically relevant biomarker.<\/jats:p>","DOI":"10.1523\/jneurosci.1829-22.2023","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T18:09:18Z","timestamp":1680026958000},"page":"3567-3581","source":"Crossref","is-referenced-by-count":10,"title":["Single Systemic Administration of a Gene Therapy Leading to Disease Treatment in Metachromatic Leukodystrophy<i>Arsa<\/i>Knock-Out Mice"],"prefix":"10.1523","volume":"43","author":[{"given":"Thia","family":"St. Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania A.","family":"Seabrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenn","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monicah","family":"Kivaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9640-2842","authenticated-orcid":false,"given":"Jason","family":"Lotterhand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mercaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kruti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel J.","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Woodcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert B.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar L.","family":"Francone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinthe","family":"Gingras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"393","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"2024061109201386000_43.19.3567.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.03.042"},{"key":"2024061109201386000_43.19.3567.2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/15513815.2018.1424277","article-title":"Gallbladder polyps in metachromatic leukodystrophy","volume":"37","author":"Almarzooqi","year":"2018","journal-title":"Fetal Pediatr Pathol"},{"key":"2024061109201386000_43.19.3567.3","doi-asserted-by":"crossref","first-page":"677895","DOI":"10.3389\/fnmol.2021.677895","article-title":"Complete correction of brain and spinal cord pathology in metachromatic leukodystrophy mice","volume":"14","author":"Audouard","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"2024061109201386000_43.19.3567.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242104"},{"key":"2024061109201386000_43.19.3567.5","doi-asserted-by":"crossref","first-page":"100604","DOI":"10.1016\/j.ymgmr.2020.100604","article-title":"Intravenous delivery for treatment of mucopolysaccharidosis type I: a comparison of AAV serotypes 9 and rh10","volume":"24","author":"Belur","year":"2020","journal-title":"Mol Genet Metab Rep"},{"key":"2024061109201386000_43.19.3567.6","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/glia.23598","article-title":"Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy","volume":"67","author":"Bergner","year":"2019","journal-title":"Glia"},{"key":"2024061109201386000_43.19.3567.7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28873"},{"key":"2024061109201386000_43.19.3567.8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/0192623318772484","article-title":"STP position paper: recommended best practices for sampling, processing, and analysis of the peripheral nervous system (nerves and somatic and autonomic ganglia) during nonclinical toxicity studies","volume":"46","author":"Bolon","year":"2018","journal-title":"Toxicol Pathol"},{"key":"2024061109201386000_43.19.3567.9","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3390\/ijms21093297","article-title":"New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand?","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2024061109201386000_43.19.3567.10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","article-title":"Gene therapy for neurodegenerative disorders: advances, insights and prospects","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"2024061109201386000_43.19.3567.11","doi-asserted-by":"publisher","DOI":"10.1038\/85454"},{"key":"2024061109201386000_43.19.3567.12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/acn3.193","article-title":"Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy","volume":"2","author":"Dali","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"2024061109201386000_43.19.3567.13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2020.07.002","article-title":"Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: results from a phase 1\/2 clinical trial","volume":"131","author":"Dali","year":"2020","journal-title":"Mol Genet Metab"},{"key":"2024061109201386000_43.19.3567.14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2889"},{"key":"2024061109201386000_43.19.3567.15","doi-asserted-by":"crossref","first-page":"100460","DOI":"10.1016\/j.ymgmr.2019.100460","article-title":"A closer look at ARSA activity in a patient with metachromatic leukodystrophy","volume":"19","author":"Doherty","year":"2019","journal-title":"Mol Genet Metab Rep"},{"key":"2024061109201386000_43.19.3567.16","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2329-07.2007"},{"key":"2024061109201386000_43.19.3567.17","doi-asserted-by":"crossref","first-page":"e0225582","DOI":"10.1371\/journal.pone.0225582","article-title":"Clade F AAVHSCs cross the blood brain barrier and transduce the central nervous system in addition to peripheral tissues following intravenous administration in nonhuman primates","volume":"14","author":"Ellsworth","year":"2019","journal-title":"PLoS One"},{"key":"2024061109201386000_43.19.3567.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0737-0"},{"key":"2024061109201386000_43.19.3567.19","unstructured":"Gomez-Ospina N (1993) Arylsulfatase A deficiency. In: GeneReviews ( Adam MP , Ardinger HH , Pagon RA , Wallace SE , Bean LJH , Mirzaa G , Amemiya A , eds). Seattle: University of Washington."},{"key":"2024061109201386000_43.19.3567.20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.25.14821"},{"key":"2024061109201386000_43.19.3567.21","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2016.087"},{"key":"2024061109201386000_43.19.3567.22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jss.2016.08.081","article-title":"Gallbladder abnormalities in children with metachromatic leukodystrophy","volume":"208","author":"Kim","year":"2017","journal-title":"J Surg Res"},{"key":"2024061109201386000_43.19.3567.23","doi-asserted-by":"publisher","DOI":"10.1021\/bi9714924"},{"key":"2024061109201386000_43.19.3567.24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/clinchem\/43.8.1325","article-title":"Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker","volume":"43","author":"Meikle","year":"1997","journal-title":"Clin Chem"},{"key":"2024061109201386000_43.19.3567.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706198"},{"key":"2024061109201386000_43.19.3567.26","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(91)90434-D"},{"key":"2024061109201386000_43.19.3567.27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bjc.1976.83","article-title":"Comparison of tumour susceptibility among various organs of foetal, young and adult ICR\/Jcl mice","volume":"33","author":"Nomura","year":"1976","journal-title":"Br J Cancer"},{"key":"2024061109201386000_43.19.3567.28","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1089\/hum.2009.031","article-title":"Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders","volume":"20","author":"Paneda","year":"2009","journal-title":"Hum Gene Ther"},{"key":"2024061109201386000_43.19.3567.29","first-page":"729","article-title":"Developing therapeutic approaches for metachromatic leukodystrophy","volume":"7","author":"Patil","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"2024061109201386000_43.19.3567.30","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2012.015"},{"key":"2024061109201386000_43.19.3567.31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainresbull.2019.05.024","article-title":"Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors","volume":"150","author":"Puhl","year":"2019","journal-title":"Brain Res Bull"},{"key":"2024061109201386000_43.19.3567.32","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S57682"},{"key":"2024061109201386000_43.19.3567.33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jnr.23792","article-title":"Gene therapy for metachromatic leukodystrophy","volume":"94","author":"Rosenberg","year":"2016","journal-title":"J Neurosci Res"},{"key":"2024061109201386000_43.19.3567.34","doi-asserted-by":"publisher","DOI":"10.1038\/ng1095-170"},{"key":"2024061109201386000_43.19.3567.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2004.03.008"},{"key":"2024061109201386000_43.19.3567.36","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi425"},{"key":"2024061109201386000_43.19.3567.37","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302883"},{"key":"2024061109201386000_43.19.3567.38","doi-asserted-by":"crossref","first-page":"576221","DOI":"10.3389\/fmed.2020.576221","article-title":"Metachromatic leukodystrophy: diagnosis, modeling, and treatment approaches","volume":"7","author":"Shaimardanova","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2024061109201386000_43.19.3567.39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10048-014-0390-4","article-title":"A novel homozygous splicing mutation in PSAP gene causes metachromatic leukodystrophy in two Moroccan brothers","volume":"15","author":"Siri","year":"2014","journal-title":"Neurogenetics"},{"key":"2024061109201386000_43.19.3567.40","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.107"},{"key":"2024061109201386000_43.19.3567.41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.omtm.2020.02.001","article-title":"Effective multi-lineage engraftment in a mouse model of fanconi anemia using non-genotoxic antibody-based conditioning","volume":"17","author":"Srikanthan","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2024061109201386000_43.19.3567.42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ymthe.2019.11.012","article-title":"A safe and reliable technique for CNS delivery of AAV vectors in the cisterna magna","volume":"28","author":"Taghian","year":"2020","journal-title":"Mol Ther"},{"key":"2024061109201386000_43.19.3567.43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1212\/WNL.0000000000002811","article-title":"Gallbladder and the risk of polyps and carcinoma in metachromatic leukodystrophy","volume":"87","author":"van Rappard","year":"2016","journal-title":"Neurology"},{"key":"2024061109201386000_43.19.3567.44","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2147\/DDDT.S139601","article-title":"Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future","volume":"11","author":"Whiteman","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"2024061109201386000_43.19.3567.45","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-004-0883-6"},{"key":"2024061109201386000_43.19.3567.46","doi-asserted-by":"crossref","first-page":"e0195186","DOI":"10.1371\/journal.pone.0195186","article-title":"Nonclinical comparability studies of recombinant human arylsulfatase A addressing manufacturing process changes","volume":"13","author":"Wright","year":"2018","journal-title":"PLoS One"},{"key":"2024061109201386000_43.19.3567.47","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.68"},{"key":"2024061109201386000_43.19.3567.48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/humc.2014.139","article-title":"Intracerebral gene therapy using AAVrh.10-hARSA recombinant vector to treat patients with early-onset forms of metachromatic leukodystrophy: preclinical feasibility and safety assessments in nonhuman primates","volume":"26","author":"Zerah","year":"2015","journal-title":"Hum Gene Ther Clin Dev"},{"key":"2024061109201386000_43.19.3567.49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.2.725"}],"container-title":["The Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.1829-22.2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T06:31:49Z","timestamp":1729146709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jneurosci.org\/lookup\/doi\/10.1523\/JNEUROSCI.1829-22.2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":49,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,5,10]]},"published-print":{"date-parts":[[2023,5,10]]}},"alternative-id":["10.1523\/JNEUROSCI.1829-22.2023"],"URL":"https:\/\/doi.org\/10.1523\/jneurosci.1829-22.2023","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1523\/jneurosci.1829-22.2023.f4-1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1523\/jneurosci.1829-22.2023.f6-1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1523\/jneurosci.1829-22.2023.f7-1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1523\/jneurosci.1829-22.2023.f8-1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1523\/jneurosci.1829-22.2023.f8-2","asserted-by":"subject"}]},"ISSN":["0270-6474","1529-2401"],"issn-type":[{"value":"0270-6474","type":"print"},{"value":"1529-2401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]}}}